SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-018686
Filing Date
2022-07-06
Accepted
2022-07-06 16:15:38
Documents
21
Period of Report
2022-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61519
2 ex4-6.htm EX-4.6 210648
3 ex4-7.htm EX-4.7 121599
4 ex10-1.htm EX-10.1 353851
5 ex10-2.htm EX-10.2 174750
6 ex10-3.htm EX-10.3 105940
7 ex10-4.htm EX-10.4 224339
8 ex10-5.htm EX-10.5 1188292
9 ex99-1.htm EX-99.1 15807
  Complete submission text file 0001493152-22-018686.txt   2964848

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ensc-20220706.xsd EX-101.SCH 3704
11 XBRL DEFINITION FILE ensc-20220706_def.xml EX-101.DEF 26619
12 XBRL LABEL FILE ensc-20220706_lab.xml EX-101.LAB 36693
13 XBRL PRESENTATION FILE ensc-20220706_pre.xml EX-101.PRE 25243
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5430
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 221068873
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences